Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 13

    Bristol-Myers Squibb’s ORENCIA Receives FDA Approval for Treatment of Active Psoriatic Arthritis

    Bristol-Myers Squibb’s ORENCIA Receives FDA Approval for Treatment of Active Psoriatic Arthritis

    supriya kashyap kashyap8 July 2017 9:16 AM IST
    Princeton : Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration (FDA) has approved ORENCIA for the treatment of adults with...
    Sanofi, Regeneron gets EU approval to market Rheumatoid Arthritis drug Kevzara

    Sanofi, Regeneron gets EU approval to market Rheumatoid Arthritis drug Kevzara

    Ruby Khatun Khatun7 July 2017 1:24 PM IST
    Sanofi and Regeneron Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the...
    Medical representatives not equipped to meet doctors changing needs: Global Study

    Medical representatives not equipped to meet doctors changing needs: Global Study

    Ruby Khatun Khatun5 July 2017 12:54 PM IST
    The study reveals compelling evidence that suggests that healthcare reps are not fully equipped to meet the changing needs of health care...
    Sun Pharma ,Samsung BioLogics announce 55.5 million dollar tie-up for psoriasis drug Tildrakizumab

    Sun Pharma ,Samsung BioLogics announce 55.5 million dollar tie-up for psoriasis drug Tildrakizumab

    Ruby Khatun Khatun5 July 2017 12:40 PM IST
    Mumbai: Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by...
    CDSCO approves marketing of Russian biosimilar of rituximab in India

    CDSCO approves marketing of Russian biosimilar of rituximab in India

    Ruby Khatun Khatun5 July 2017 12:38 PM IST
    SAINT PETERSBURG: On 20th of June 2017, the Central Drugs Standard Control Organization (CDSCO) has recommended Acellbia, the first rituximab...
    Govt-patented Microwave Medical Waste Disinfection System requests intervention for policy provision to find place in Government eMarketplace

    Govt-patented Microwave Medical Waste Disinfection System requests intervention for policy provision to find place in Government eMarketplace

    Ruby Khatun Khatun3 July 2017 9:27 AM IST
    New Delhi: A government patented microwave technology for medical waste disinfection, OptiMaser is an eco-friendly technology which is working towards...
    Sandoz receives approval in Europe for Erelzi to treat multiple inflammatory diseases

    Sandoz receives approval in Europe for Erelzi to treat multiple inflammatory diseases

    Ruby Khatun Khatun29 Jun 2017 9:58 AM IST
    Holzkirchen: Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced that the European Commission (EC) has approved...
    Natco Pharma receives final approval for generic Azacitidine for injection for USA market

    Natco Pharma receives final approval for generic Azacitidine for injection for USA market

    Ruby Khatun Khatun28 Jun 2017 12:37 PM IST
    Hyderabad: Natco Pharma Limited announced that it has got the final approval of Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug...
    Pharma Doyen, Lupin founder passes away

    Pharma Doyen, Lupin founder passes away

    Ruby Khatun Khatun27 Jun 2017 3:03 PM IST
    Mumbai: Dr Desh Bandhu Gupta, Founder and Chairman of Lupin Limited (Lupin), passed away early this morning in Mumbai. He was 79 years old. He will be...
    FDA approves betrixaban for the prophylaxis of venous thromboembolism in adult patients

    FDA approves betrixaban for the prophylaxis of venous thromboembolism in adult patients

    supriya kashyap kashyap27 Jun 2017 12:48 PM IST
    The U.S. Food and Drug Administration approved betrixaban (BEVYXXA, Portola) for the prophylaxis of venous thromboembolism (VTE) in adult patients...
    Sun Pharma and NIV sign agreement to fight Zika, Chikungunya and Dengue

    Sun Pharma and NIV sign agreement to fight Zika, Chikungunya and Dengue

    Ruby Khatun Khatun27 Jun 2017 12:46 PM IST
    Mumbai, Pune & New Delhi: Sun Pharma and The National Institute of Virology (NIV), Pune, an institution of the Indian Council of Medical Research,...
    Natco Pharma CEO Donates Rs 15 Crore to L V Prasad Eye Institute for children eye care

    Natco Pharma CEO Donates Rs 15 Crore to L V Prasad Eye Institute for children eye care

    Ruby Khatun Khatun24 Jun 2017 11:27 AM IST
    Hyderabad: Mr Rajeev Nannapaneni, Vice Chairman and CEO, Natco Pharma Limited, donated 1.5 lakh shares valued at Rs 15 crores to Hyderabad Eye...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Indian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: Report

    Indian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: Report

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok